PFM Health Sciences’s Fortrea Holdings FTRE Stock Holding History

PFM Health Sciences’s Portfolio FTRE Stock Details FTRE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-165,439	Closed	-$2.85M	–	89
2025 Q4	$2.85M	Buy	+165,439	New	+$2.04M	0.28%	65

Other funds holding FTRE

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Corvex Management New York $3.27B AUM 38.53% 1-Year Est. Return

Sessa Capital New York $5.98B AUM 99.85% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

PFM Health Sciences's FTRE Position: Q1 2026 in Review

PFM Health Sciences sold out of Fortrea Holdings (FTRE) in Q1 2026, closing a stake of 165,439 shares — an estimated $2.85M sold.

PFM Health Sciences first reported a position in FTRE in Q4 2025 and held it in 1 quarter. The position peaked at $2.85M in Q4 2025. 331 funds tracked by Wall St. Rank hold FTRE as of Q1 2026.

PFM Health Sciences reported no remaining Fortrea Holdings position as of Q1 2026 after selling out during the quarter.
PFM Health Sciences sold 165,439 Fortrea Holdings shares in Q1 2026, an estimated $2.85M.
PFM Health Sciences first reported a position in Fortrea Holdings in Q4 2025 and held it in 1 quarter.
PFM Health Sciences's Fortrea Holdings position peaked at $2.85M in Q4 2025.
331 funds tracked by Wall St. Rank held Fortrea Holdings as of Q1 2026.

Based on PFM Health Sciences's 13F filing for Q1 2026, filed 15 May 2026.